Taking Action to Accelerate Our Transformation and Support 
Long-Term Success

Learn More

Rite Aid is taking steps to strengthen our company as we continue delivering the products and services our customers need to live healthier, happier lives.

We have reached an agreement in principle with certain of our financial stakeholders on the terms of a financial restructuring plan that will allow us to accelerate Rite Aid’s ongoing business transformation. Implementing the contemplated restructuring plan will significantly reduce the Company’s debt, increase our financial flexibility and enable us to execute on key initiatives. In connection with this, Rite Aid has initiated a voluntary court-supervised process under Chapter 11 of the U.S. Bankruptcy Code.

As we move through this process, Rite Aid remains focused on providing leading healthcare products and services that improve the health outcomes of the nearly one million customers that we serve daily.

Continuing to Serve Customers Across Our Retail and Online Platforms

During the court-supervised process, Rite Aid will continue:

Serving our retail, 
pharmacy and PBM customers
Working with vendors, suppliers and business partners
Paying associates and providing benefits

Additional Information About the Court-Supervised Process

Rite Aid and certain of its subsidiaries filed voluntary petitions for Chapter 11 reorganization in the U.S. Bankruptcy Court for the District of New Jersey. Elixir Insurance is not included in the court-supervised process.

The court-supervised process provides an orderly and efficient forum for Rite Aid to:

  • Finalize and build consensus for the agreement in principle with the financial stakeholders;
  • Accelerate the Company’s store footprint optimization plan;
  • Implement the sale of Elixir Solutions to MedImpact Healthcare Systems, Inc., which was completed on February 1, 2024;
  • Access additional liquidity; and
  • Resolve litigation claims in an equitable manner.

In connection with this process, we have received a commitment for $3.45 billion in debtor-in-possession financing. This financing is expected to provide sufficient liquidity to support the business throughout the court-supervised process.

Press Releases

Rite Aid Completes Sale of Majority of Health Dialog Assets
Download PDF
Rite Aid Enters into Agreement to Divest Majority of Health Dialog Assets
Download PDF
Rite Aid Completes Sale of Elixir Solutions to MedImpact
Download PDF
Rite Aid Receives Court Approval for Sale of Elixir Solutions Business to MedImpact
Download PDF
Rite Aid Receives Court Approval of "First Day" Motions to Support Business Operations
Download PDF
Rite Aid Takes Steps to Accelerate Transformation and Position Company for Long-Term Success
Download PDF
Rite Aid Corporation Appoints Jeffrey S. Stein Chief Executive Officer
Download PDF

Information & Resources

Fact Sheets

Stakeholder Fact Sheet
Download PDF
Customer Fact Sheet
Download PDF
Retail Customer Information
open and close section
Retail Customer Letter
Retail Customer FAQ
PBM Information
open and close section
PBM Letter
Supplier & Vendor Information
open and close section
Supplier & Vendor Letter
Supplier & Vendor FAQ
Former Associates & Retirees
open and close section
Former Associate & Retiree Letter
Former Associate & Retiree FAQ
Investor Information
open and close section
Shareholder FAQ